Core Viewpoint - Corning Jereh Pharmaceutical-B (09966) shares rose over 3%, currently trading at HKD 13.46 with a transaction volume of HKD 31.44 million, following the announcement of a share buyback plan [1] Group 1: Share Buyback Announcement - The company announced a share buyback authorization, with a maximum repurchase amount of HKD 20 million, subject to shareholder approval at the annual general meeting on June 12, 2025 [1] - The board believes that the current trading price does not accurately reflect the company's intrinsic value and that the buyback will demonstrate confidence in the company's business outlook and prospects [1] - The board is confident that the company's current financial resources are sufficient to support the proposed buyback while maintaining a robust financial position [1]
康宁杰瑞制药-B涨超3% 拟进行场内股份购回 金额上限为2000万港元